Evidence map›Paper›PMID 28680568›Full record

ArticlePulmonary circulation2017

Combined oral administration of L-arginine and tetrahydrobiopterin in a rat model of pulmonary arterial hypertension.

C Schreiber, M S Eilenberg, A Panzenboeck, M P Winter, H Bergmeister, R Herzog, J Mascherbauer, I M Lang, D Bonderman

Open access · hybridAbstract read
In one paragraph

Article in Pulmonary circulation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Oral Delivery Systems for Gasotransmitters in Therapeutic Applications.Polymer science & technology (Washington, D.C.) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Oxidative stress induces BHBioscience reports · 2018
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

C SchreiberDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria.
M S EilenbergDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria.
A PanzenboeckDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria.
M P WinterDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria.
H BergmeisterInstitute of Biomedical Research, Medical University of Vienna, Austria.
R HerzogDepartment of Pediatrics and Adolescent Medicine, Medical University of Vienna, Austria.
J MascherbauerDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria.
I M LangDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria.
D BondermanDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria.
Medical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alterations in the nitric oxide (NO) pathway play a major role in pulmonary arterial hypertension (PAH). L-arginine (LA) and tetrahydrobiopterin (BH

Indexed as

animal modelcombination therapyL-argininemonocrotalinepulmonary arterial hypertension (PAH)tetrahydrobiopterin

Identifiers

PMID28680568
PMCPMC5448548
OpenAlexW2556249078

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.